Evidence map›Paper›PMID 40015980›Full record

ArticleGenome research2025

A prospective trial comparing programmable targeted long-read sequencing and short-read genome sequencing for genetic diagnosis of cerebellar ataxia.

Haloom Rafehi, Liam G Fearnley, Justin Read, Penny Snell, Kayli C Davies, Liam Scott, Greta Gillies, Genevieve C Thompson, Tess A Field, Aleena Eldo and 32 more

Abstract readComparative Study
In one paragraph

Article in Genome research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Unravelling the Global Tapestry of Genetic Ataxias: Epidemiology and Genetic Testing Approaches.Movement disorders : official journal of the Movement Disorder Society · 2025
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Haloom Rafehi *Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.
Liam G Fearnley *Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.
Justin Read *Bruce Lefroy Centre, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.
Penny SnellBruce Lefroy Centre, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.
Kayli C DaviesBruce Lefroy Centre, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.
Liam ScottPopulation Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.
Greta GilliesBruce Lefroy Centre, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.
Genevieve C ThompsonBruce Lefroy Centre, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.
Tess A FieldBruce Lefroy Centre, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.
Aleena EldoBruce Lefroy Centre, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.
Simon BodekAustin Health, Heidelberg, Victoria 3084, Australia.
Ernest ButlerMonash Medical Centre, Clayton, Victoria 3168, Australia.
Luke ChenDepartment of Neurology, Alfred Hospital, Melbourne, Victoria 3004, Australia.
John DragoDepartment of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria 3065, Australia.
Himanshu GoelHunter Genetics, Hunter New England Health Service, Waratah, New South Wales 2298, Australia.
Anna HackettHunter Genetics, Hunter New England Health Service, Waratah, New South Wales 2298, Australia.
G Michael HalmagyiNeurology Department, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia.
Andrew HannafordDepartment of Neurology, Westmead Hospital, Hawkesbury Westmead, New South Wales 2145, Australia.
Katya KotschetDepartment of Clinical Neurosciences, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria 3065, Australia.
Kishore R KumarMolecular Medicine Laboratory and Neurology Department, Concord Repatriation General Hospital, Concord, New South Wales 2139, Australia.
Smitha KumbleVictorian Clinical Genetics Services, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.
Matthew Lee-ArcherDepartment of Neurology, Launceston General Hospital, Launceston, Tasmania 7250, Australia.
Abhishek MalhotraDepartment of Neuroscience, University Hospital Geelong, Geelong, Victoria 3220, Australia.
Mark PaineDepartment of Neurology, Royal Brisbane and Women's Hospital, Herston, Queensland 4006, Australia.
Michael PoonNeurology Footscray, Footscray, Victoria 3011, Australia.
Kate PopeBruce Lefroy Centre, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.
Katrina ReardonDepartment of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria 3065, Australia.
Steven RingAlbury Wodonga Health, West Albury, New South Wales 2640, Australia.
Anne RonanUniversity of Newcastle, Callaghan, New South Wales 2308, Australia.
Matthew SilsbyDepartment of Neurology, Westmead Hospital, Hawkesbury Westmead, New South Wales 2145, Australia.
Renee SmythSt Vincent's Clinical Genomics, St Vincent's Hospital, Darlinghurst, New South Wales 2010, Australia.
Chloe StutterdVictorian Clinical Genetics Services, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.
Mathew WallisTasmanian Clinical Genetics Service, Tasmanian Health Service, Royal Hobart Hospital, Hobart, Tasmania 7001, Australia.
John WaterstonDepartment of Neuroscience, Central Clinical School, Monash University, The Alfred Centre, Melbourne, Victoria 3004, Australia.
Thomas WellingsDepartment of Neurology, John Hunter Hospital, New Lambton Heights, New South Wales 2305, Australia.
Kirsty WestGenomic Medicine, The Royal Melbourne Hospital, Parkville, Victoria 3052, Australia.
Christine WoolsDepartment of Neurology, Calvary Health Care Bethlehem, Caulfield South Victoria 3162, Australia.
Kathy H C WuSt Vincent's Clinical Genomics, St Vincent's Hospital, Darlinghurst, New South Wales 2010, Australia.
David J SzmulewiczRoyal Victorian Eye and Ear Hospital, East Melbourne, Victoria 3002, Australia.
Martin B DelatyckiBruce Lefroy Centre, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.
Melanie Bahlo *Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia.ORCID 0000-0001-5132-0774
Paul J Lockhart *Bruce Lefroy Centre, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia; paul.lockhart@mcri.edu.au.ORCID 0000-0003-2531-8413

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cerebellar ataxias (CAs) are a heterogeneous group of disorders characterized by progressive incoordination. Seventeen repeat expansion (RE) loci have been identified as the primary genetic cause and account for >80% of genetic diagnoses. Despite this, diagnostic testing is limited and inefficient, often utilizing single gene assays. This study evaluates the effectiveness of long- and short-read sequencing as diagnostic tools for CA. We recruited 110 individuals (48 females, 62 males) with a clinical diagnosis of CA. Short-read genome sequencing (SR-GS) was performed to identify pathogenic RE and also non-RE variants in 356 genes associated with CA. Independently, long-read sequencing with adaptive sampling (LR-AS) was performed to identify pathogenic RE. SR-GS provided a genetic diagnosis for 38% of the cohort (40/110) including seven non-RE pathogenic variants. RE causes disease in 33 individuals, with the most common condition being SCA27B (

Indexed as

Cerebellar AtaxiaGenetic TestingHigh-Throughput Nucleotide SequencingAdolescentAdultAgedDNA Repeat ExpansionFemaleGenome, HumanHumansMaleMiddle AgedProspective StudiesSequence Analysis, DNAWhole Genome Sequencing

Identifiers

PMID40015980
PMCPMC12047251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.